HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiation-induced craniofacial bone growth inhibition: acute and long-term effects on bone histopathology with and without cytoprotection.

AbstractBACKGROUND:
The authors previously established an animal model of radiation-induced craniofacial bone growth inhibition and demonstrated the effectiveness of cytoprotection in preserving growth using amifostine, but the mechanism is unclear. The objective of this study was to investigate the acute and long-term histopathologic effects of single-dose orthovoltage irradiation on craniofacial bone with and without cytoprotection.
METHODS:
Sixty infant New Zealand White rabbits (7-week-old) were randomized into three groups (n = 20 per group): group 1, 0-Gy, sham irradiation; group 2, 35-Gy single-dose orthovoltage irradiation; and group 3, cytoprotection with amifostine before irradiation. Orbitozygomatic complex bone was harvested from animals 12 hours after irradiation and at skeletal maturity (21 weeks of age). Histologic parameters measured included native bone cell (osteoblast, osteoclast, and osteocyte) populations, periosteal proliferation indices (MIB-1 stains), bone turnover rates [triple fluorochromes: tetracycline administered at 7 weeks of age (before irradiation), alizarin complexone at 12 weeks, and calcein at 16 weeks of age], and endosteal space fibrosis levels.
RESULTS:
Orthovoltage irradiation significantly (p < 0.05) reduced osteoblast and osteoclast counts 12 hours after irradiation (age, 7 weeks) with or without pretreatment with amifostine but had no effect on osteocyte populations. Long-term analysis at age 21 weeks demonstrated significantly (p < 0.05) increased osteoblast counts, reduced endosteal space fibrosis, reduced periosteal proliferation indices, and improved bone turnover (fluorochrome stains) in amifostine-treated animals.
CONCLUSION:
This study suggests that amifostine cytoprotection is mediated through a combination of reduced cellular injury with enhanced promotion of cellular bone rebuilding potential.
AuthorsDavid A O'Donovan, Giorgio C La Scala, Iona Leong, Maria Mendes, Marianne Rogers, Kenneth H Pritzker, Ivan Yeung, Cho Y Pang, Peter C Neligan, Christopher R Forrest
JournalPlastic and reconstructive surgery (Plast Reconstr Surg) Vol. 129 Issue 4 Pg. 636e-645e (Apr 2012) ISSN: 1529-4242 [Electronic] United States
PMID22456377 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ki-67 Antigen
  • Radiation-Protective Agents
  • Amifostine
Topics
  • Amifostine (pharmacology)
  • Animals
  • Bone Remodeling
  • Cell Proliferation (drug effects, radiation effects)
  • Dose-Response Relationship, Radiation
  • Ki-67 Antigen (analysis)
  • Male
  • Orbit (drug effects, growth & development, pathology, radiation effects)
  • Osteoblasts (drug effects, pathology, radiation effects)
  • Periosteum (metabolism, pathology)
  • Rabbits
  • Radiation Dosage
  • Radiation-Protective Agents (pharmacology)
  • Zygoma (drug effects, growth & development, pathology, radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: